X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs UNICHEM LAB - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN LTD UNICHEM LAB LUPIN LTD/
UNICHEM LAB
 
P/E (TTM) x 26.1 -66.7 - View Chart
P/BV x 2.7 0.7 365.9% View Chart
Dividend Yield % 0.6 2.3 26.8%  

Financials

 LUPIN LTD   UNICHEM LAB
EQUITY SHARE DATA
    LUPIN LTD
Mar-18
UNICHEM LAB
Mar-18
LUPIN LTD/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,465382 383.5%   
Low Rs727234 310.6%   
Sales per share (Unadj.) Rs349.6116.3 300.6%  
Earnings per share (Unadj.) Rs5.6-18.9 -29.4%  
Cash flow per share (Unadj.) Rs29.6-11.7 -251.9%  
Dividends per share (Unadj.) Rs5.005.00 100.0%  
Dividend yield (eoy) %0.51.6 28.1%  
Book value per share (Unadj.) Rs300.3381.0 78.8%  
Shares outstanding (eoy) m452.0870.34 642.7%   
Bonus/Rights/Conversions ESOPSBB-  
Price / Sales ratio x3.12.6 118.4%   
Avg P/E ratio x197.2-16.3 -1,211.3%  
P/CF ratio (eoy) x37.1-26.2 -141.2%  
Price / Book Value ratio x3.60.8 451.4%  
Dividend payout %90.0-26.4 -340.4%   
Avg Mkt Cap Rs m495,50221,668 2,286.8%   
No. of employees `00017.02.3 747.5%   
Total wages/salary Rs m28,6472,006 1,427.8%   
Avg. sales/employee Rs Th9,273.63,587.8 258.5%   
Avg. wages/employee Rs Th1,681.0880.0 191.0%   
Avg. net profit/employee Rs Th147.4-583.7 -25.3%   
INCOME DATA
Net Sales Rs m158,0428,180 1,932.0%  
Other income Rs m1,504610 246.4%   
Total revenues Rs m159,5458,790 1,815.0%   
Gross profit Rs m31,475-1,320 -2,384.1%  
Depreciation Rs m10,859505 2,149.8%   
Interest Rs m2,04480 2,551.2%   
Profit before tax Rs m20,076-1,295 -1,549.9%   
Minority Interest Rs m-710-   
Prior Period Items Rs m35-2 -1,600.0%   
Extraordinary Inc (Exp) Rs m-14,6440-   
Tax Rs m2,88533 8,631.4%   
Profit after tax Rs m2,513-1,331 -188.8%  
Gross profit margin %19.9-16.1 -123.4%  
Effective tax rate %14.4-2.6 -556.9%   
Net profit margin %1.6-16.3 -9.8%  
BALANCE SHEET DATA
Current assets Rs m122,09523,318 523.6%   
Current liabilities Rs m50,9564,635 1,099.3%   
Net working cap to sales %45.0228.4 19.7%  
Current ratio x2.45.0 47.6%  
Inventory Days Days85122 69.5%  
Debtors Days Days120121 98.7%  
Net fixed assets Rs m129,8768,163 1,591.0%   
Share capital Rs m904141 642.6%   
"Free" reserves Rs m134,86626,660 505.9%   
Net worth Rs m135,77126,801 506.6%   
Long term debt Rs m64,2453 1,946,818.2%   
Total assets Rs m263,05431,890 824.9%  
Interest coverage x10.8-15.2 -71.3%   
Debt to equity ratio x0.50 384,297.4%  
Sales to assets ratio x0.60.3 234.2%   
Return on assets %1.7-3.9 -44.2%  
Return on equity %1.9-5.0 -37.3%  
Return on capital %3.7-4.5 -81.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m53,1414,356 1,219.8%   
Fx outflow Rs m19,3350-   
Net fx Rs m33,8074,356 776.0%   
CASH FLOW
From Operations Rs m17,512-1,123 -1,558.8%  
From Investments Rs m-14,07316,487 -85.4%  
From Financial Activity Rs m-14,921-8,811 169.3%  
Net Cashflow Rs m-11,4826,552 -175.2%  

Share Holding

Indian Promoters % 46.6 50.1 93.0%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 15.1 74.8%  
FIIs % 31.9 3.0 1,063.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 31.7 31.9%  
Shareholders   98,259 20,176 487.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN LTD With:   IPCA LABS  NOVARTIS  DR. DATSONS LABS  MERCK LTD  SANOFI INDIA  

Compare LUPIN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Up Over 240 Points; Rupee Touches Record Low(12:30 pm)

After opening the day in the green, stock markets in India have continued their momentum and are presently trading on a positive note.

Related Views on News

LUPIN LTD Announces Quarterly Results (1QFY19); Net Profit Up 21.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, LUPIN LTD has posted a net profit of Rs 4 bn (up 21.3% YoY). Sales on the other hand came in at Rs 26 bn (up 3.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Should You Buy These Mouthwatering High Dividend Stocks?(Profit Hunter)

Aug 1, 2018

Many stocks are yielding dividends even upwards of 4%-5%. Here are the kinds you should pick, and the ones to avoid.

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

NFO - Axis Equity Hybrid Fund: A Worthy Proposition?(Outside View)

Aug 1, 2018

PersonalFN explains if NFO: Axis Equity Hybrid Fund, would be a worthy proposition currently.

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Aug 14, 2018 02:05 PM

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE LUPIN LTD WITH

MARKET STATS